Patent ID: 11897966
Assignee: UTC THERAPEUTICS (SHANGHAI) CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC C

Claim 0:
1. An antibody or antigen-binding fragment thereof that specifically binds mesothelin and comprises a VL CDR1, a VL CDR2, a VL CDR3, a VH CDR1, a VH CDR2 and a VH CDR3, wherein
(a) the VL CDR1, CDR2 and CDR3 have the amino acid sequences of SEQ ID NOs: 1, 2, and 3 respectively; and
(b) the VH CDR1, CDR2 and CDR3 have the amino acid sequences of SEQ ID NOs: 4, 5, and 6 respectively.